Global stock

BRUEUR

Solvay SA

SOLB.BR

AI analysis and articles are in Czech.

§ Financial healthLong-term stability

48/ 100

Overall score·SOLB.BR

Current price

23.24EUR

23/10/2026

P/E, P/B

Valuation

Strong

Rates whether the stock is cheap or expensive relative to its history and sector. A score above 60 suggests the stock trades below its estimated intrinsic value.

Tracks:P/E · P/B · FCF yield · sector

Nízké forward P/E, PEG a EV/EBITDA naznačují příznivější ocenění, zatímco mimořádně vysoké trailing P/E odráží velmi nízký současný zisk. Slabý růst tržeb, nízké marže a vysoké zadlužení jsou nejslabšími stránkami; cena je pod oběma uvedenými klouzavými průměry.

§ Outlook vs S&P 500Next 12 months

Probably yes

Estimated chance of beating the index: about 56%

7 of 8 inputs

NoProbably notSameProbably yesYes

A model estimate from current values. The result may change with new data; it is not a price target or an investment recommendation.

§ Metrics summary

A quick look at Solvay SA (SOLB.BR) combining financial health, the short-term signal, valuation, DCF, management quality and operating metrics. It is analytical context, not a recommendation to buy or sell.

48/100

The overall score is based mainly on long-term fundamentals, complemented by the current signal and the available qualitative rating of the company.

—

Not enough fresh news.

73/100

A lower score means the stock is expensive relative to the company's earnings and assets.

65% below fair value

An estimate of what the stock should be worth based on the company's future cash.

-6%

How fast the company's revenue grows year on year.

27/100

How much the company earns from each unit of revenue and from invested capital.

35/100

Debt level, share-price volatility and how resilient the company is in bad times.

63/100

AI estimate of management quality, execution and capital allocation.

67/100

AI estimate of the company's durable competitive advantage.

§ Financial results

Financial results·SOLB.BR

mld. EUR

RevenueEBITDANet incomeEBITDA margin

Margins and profitability·SOLB.BR

Net marginEBITDA marginDashed = estimate

Net margin

+0.7 %

FY 2025 · reported

EBITDA margin

+16.1 %

FY 2026 · estimate

Net margin

+0.1 %

last 12 months

Operating margin

+6.4 %

last 12 months

ROE

+0.8 %

last 12 months

FY = fiscal year · TTM = trailing 12 months

§ Context and events

Management

Generálním ředitelem a předsedou výkonného výboru je Philippe Kehren. Finanční a strategickou oblast vede Alexandre Blum, provozním ředitelem je Lanny Duvall. Strategie Solvay se po oddělení Syensqo opírá o zaměření na základní a speciální chemikálie a provozní výkonnost.

Articles about Solvay SA, in Czech (0)

No articles yet. New analyses are published daily.

§ Upcoming results

4 November 2026

in 8 days

Earnings

Earnings = quarterly financial results (revenue and profit). Companies publish them every three months and the share price often reacts strongly.

§ Frequently asked questions

What is Solvay SA (SOLB.BR)?

Solvay SA (SOLB.BR) is a global stock traded on BRU. We track it daily — scoring news sentiment, the short-term outlook and long-term stability on a 0–100 scale.

What is the Solvay SA price today?

As of 23 October 2026, Solvay SA trades at about 23.24 EUR per unit. We update the price daily from public market data. Intraday moves can differ significantly — always check the final price with your broker.

How to buy Solvay SA?

Through regulated online brokers such as Degiro, XTB, Trading 212 or Interactive Brokers. Shares trade in USD or EUR — most brokers convert your currency automatically. FinSignal does not operate any of these platforms and charges no commission — the overview is only a signpost.

Does Solvay SA pay a dividend?

Solvay SA either pays no dividend at the moment or we have no reliable data on it. Many growth companies prefer reinvesting profit to paying dividends — check the current policy in the company's investor relations materials.

§ More global stocks

Microsoft Corporation

§ How to buy Solvay SA

You can buy shares through regulated online brokers available in the EU. They differ mainly in fees, app quality and which markets they cover.

Degiro
Dutch broker with low fees for passive investors. No account fee, trading in EUR and USD.
XTB
Polish broker with zero commission on stocks and ETFs up to EUR 100,000 a month. Own xStation platform.
Trading 212
Zero-commission broker with fractional shares from EUR 1 and automated investing (Pies). Suits beginners and regular investing.
Interactive Brokers
US broker for advanced investors. The widest choice of markets, low costs at larger volumes, a professional platform with a steeper learning curve.

FinSignal operates none of these platforms. We charge no commission on purchases.

Important: Signals are an analytical tool, not investment advice within the meaning of Czech Act No. 256/2004 Coll. Past performance does not guarantee future results. You make all decisions at your own risk.

§ Current signalShort-term mood

—

/ 100

● Data unavailable

Earnings in 8 days

On 4 November 2026 the company publishes its quarterly results. This period tends to bring large price moves — the signal below does not reflect the results yet.

Market context

No newer news

Signal 01/10, 19:01

Makro a sektorová dynamika ukazují vyrovnaný výhled pro zpracovatelský průmysl a chemický sektor; krátkodobě není jasný směr, ale technologické inovace a náklady mohou podpořit stabilitu.

Available data is limited

Signal history· 1

25/0915:0130 · Slightly negative
Tržní nálada pro Solvay zůstává mírně negativní kvůli poklesu ceny a cenovým tlakům v chemickém sektoru; technika nese signály downtrend, ale krátkodobý výhled není jednoznačný.

The full 90-day signal history is part of Premium.

Ask the AI

§ Model fair value (DCF)

Undervalued65% below fair value

66.15

range 53.2 – 84.2

Current price

23.24 EUR

23 Oct 26

PriceFair value range (DCF)UndervaluedOvervalued

What the calculation is based on

Model

66.15 EUR

range 53.2 EUR – 84.2 EUR

: 3.0%
: 9.5%
: 4.42 EUR

Růst FCF 3 % p.a. je konzervativní předpoklad vzhledem k poklesu tržeb a nízké ziskovosti. Diskontní sazba 9,5 % zohledňuje cykličnost chemického odvětví a vysoké zadlužení, přestože beta je nízká.

DCF terms explained+

DCF (discounted cash flow) estimates how much cash the company will generate in the future and converts it into today's value per share.

Free cash flow (FCF) is the money left after running the business and investing. “12 m” means the last 12 months.

The discount rate expresses risk: the riskier the company, the higher the rate and the lower the fair value.

Fair value is a model estimate — not the market price and not an investment recommendation.

With Premium you can adjust growth, the discount rate and free cash flow, and the fair value recalculates live.

Adjust assumptions14 days free →

A model estimate, not an investment recommendation. Past performance does not guarantee future results.

§ Valuation check

Is the price reasonable?

Six quick tests: price against fair value, the last year, similar companies and analyst estimates. They are calculated from the numbers, not from AI estimates. This is not a recommendation.

Data 18 of 18

Valuation score

4/ 6

6/6 tests available

1. Below DCF fair value

64.9% below the DCF midpoint.

2. Well below DCF value

Discount = below the range or at least 15% below the midpoint.

3. Price vs. the last year

0% above the 1-year low (23.24 EUR to 28.86 EUR), based on stored daily prices.

4. P/E vs. similar companies

P/E 837.3 vs. median 21.9 (26 companies).

5. P/E relative to growth

PEG 0.3; a lower value means cheaper growth.

6. Analyst price target

6.6% vs. the current price, 15 analysts.

Price vs DCF

Current price

23.24 EUR

Low 53.17 EURHigh 84.18 EUR

Current priceDCF midpoint: 66.15 EUR

Price vs analyst target

Current price

23.24 EUR

Low 20.00 EURHigh 30.00 EUR

Current priceAverage: 24.77 EUR

DCF gap

below range

64.9% below the DCF midpoint (66.15 EUR).

Analyst target

+6.6%

Average target 24.77 EUR vs. price 23.24 EUR.

Analyst consensus

Target range

20.00 EUR - 30.00 EUR

Coverage

15 analysts

Analyst consensus

3.5 / 5

Changes 180 d

+0 / -0

EPS next year

6.8%

Revenue next year

2.4%

Valuation multiples

837.3

10.1

2.5

0.6

7.8

0.3

52-week range0% above the low

23.24 EUR28.86 EUR

318.0%

-6.0%

0.1%

0.8%

Price vs 50D-9.1%

Price vs 200D-11.8%

Metrics explained+

Price and fair value

DCF range: A model estimate of fair value from future free cash flow. A price above the range means the market pays a premium over the model; a price below it may signal a more conservative market valuation or an overly optimistic model.
Analyst target: The average and range of the analyst price targets we track. It is the market consensus, not a FinSignal recommendation, and it can lag fast price moves.
52-week range: Shows where the current price sits between the low and high of the last year. A value near the high often signals strong momentum, but on its own says nothing about whether the stock is expensive.
Price vs 50D / 200D: Compares the price with its short- and long-term moving averages. A positive value means the price is above the trend; a negative one below it.

Multiples

P/E: Price relative to current earnings. A lower P/E can mean cheaper, but it can also point to a weak outlook or risk.
Forward P/E: Price relative to next year's expected earnings. For growing companies it is often more useful than the historical P/E because it reflects estimates of future earnings.
P/B: Price relative to the book value of equity. It makes more sense for banks, insurers and capital-intensive companies than for software or brands.
P/S: Price relative to revenue. It helps with companies that have low or negative earnings; a high P/S means the market expects strong growth or future margins.
EV/EBITDA: The value of the whole company, including debt, relative to operating profit before depreciation. Useful for comparing companies with different leverage.
PEG: P/E adjusted for earnings growth. A value around 1 may suggest the valuation matches growth, but the metric is sensitive to estimates.

Growth and quality

EPS growth: Year-on-year change in earnings per share. Strong growth supports a higher valuation, but for cyclical companies it can be temporary.
Revenue growth: The growth rate of sales. It helps tell whether profits grow on real demand or mainly on cost savings.
Net margin: How much of each unit of revenue is left as net profit. A higher margin often points to stronger pricing power or more efficient operations.
ROE: Return on equity. A high ROE can signal a quality business, but check that it is not artificially boosted by heavy debt.

Most data available. Missing values mean the market data source did not provide them for this ticker. The data is indicative and may be delayed. Price as of 23/10/2026.

Management and competitive advantage

Both are estimated by the AI from the company profile, news and results. They do not count towards the 6-pillar financial health score. The AI comments are in Czech.

good

Nízká uvedená governance rizika a zkušené vedení podporují solidní hodnocení, přestože dodaná data neposkytují konkrétní důkaz o dlouhodobé kvalitě exekuce.

good

Rozsáhlé portfolio chemických produktů, specializované aplikace a dlouhá historie poskytují určitou výhodu v know-how a zákaznických vztazích, avšak dostupné údaje nepotvrzují mimořádně silnou ochranu před konkurencí.

Information

Type: Global stock
Symbol: SOLB.BR
Exchange: BRU
Currency: EUR
Sector: Materiály
: 837.3x
: 2.6B USD
: 201.3 %
: 0.26

§ Risk profile

Výsledky mohou ovlivnit cyklická průmyslová poptávka, ceny energií a vstupních surovin i kurz eura vůči koruně. Provoz chemických závodů navíc podléhá přísným environmentálním pravidlům a může čelit nákladům na jejich dodržování.

Ask the AI about Solvay SA All signals